Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000316314 | SCV000229768 | likely pathogenic | not provided | 2015-02-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000316314 | SCV000330125 | pathogenic | not provided | 2016-06-27 | criteria provided, single submitter | clinical testing | The c.7366_7367delAT pathogenic variant in the ATRX gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.7366_7367delAT variant causes a frameshift starting with codon Methionine 2456, changes this amino acid to a Glutamic Acid residue, and creates a premature Stop codon at position 41 of the new reading frame, denoted p.Met2456GlufsX41. The c.7366_7367delAT variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. A protein truncating pathogenic variant downstream of this variant has been reported in the Human Gene Mutation Database in association with ATRX-related disorders (Stenson et al., 2014), supporting the pathogenicity of more upstream truncating variants. We interpret c.7366_7367delAT as a pathogenic variant. |